Millennium Management
CADX

Millennium Management’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Millennium Management’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-899,161
Closed -$8.14M – 4271
2013
Q4 		$8.14M Buy
899,161
+803,874
+844% +$5.8M 0.03% 843
2013
Q3 		$600K Sell
95,287
-22,774
-19% -$145K ﹤0.01% 2425
2013
Q2 		$805K Buy
+118,061
New +$822K ﹤0.01% 2070

Other funds holding CADX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management's CADX Position: Q1 2014 in Review

Millennium Management sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 899,161 shares — an estimated $8.14M sold.

Millennium Management first reported a position in CADX in Q2 2013 and held it in 3 quarters. The position peaked at $8.14M in Q4 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

  • Millennium Management reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
  • Millennium Management sold 899,161 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $8.14M.
  • Millennium Management first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q2 2013 and held it in 3 quarters.
  • Millennium Management's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $8.14M in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on Millennium Management's 13F filing for Q1 2014, filed 15 May 2014.